NCT05051358 (TEUS Registry) is a clinical trial of Therapeutic Endoscopic Ultrasound in Therapeutic Endoscopic Ultrasound, sponsored by Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University.

What drugs are being tested in NCT05051358?

Interventions in NCT05051358: Therapeutic Endoscopic Ultrasound.

What condition does NCT05051358 study?

NCT05051358 studies Therapeutic Endoscopic Ultrasound, Advanced Endoscopy, Therapeutic Endoscopy, Interventional Endoscopy, Interventional Endoscopic Ultrasound, Gastro-Intestinal Disorder, Gastrointestinal Disease, Gastrointestinal Cancer, Gastrointestinal Dysfunction, Gastrointestinal Fistula, Gastrointestinal Infection, Gastrointestinal Injury, Pancreatic Disease, Bile Duct Diseases.

Is NCT05051358 still recruiting?

NCT05051358 is currently status unknown. Last updated 26 May 2023.

Last reviewed 2023-05-26 · How we verify

NCT05051358: TEUS Registry

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study

Status unknown Last updated 26 May 2023

What this trial tests

trial testing Therapeutic Endoscopic Ultrasound in Therapeutic Endoscopic Ultrasound in 5,000 participants. Status unknown.

Timeline

11 February 2021

Primary endpoint
10 December 2023

10 December 2023

Quick facts

Lead sponsor	Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	11 February 2021
Primary completion	10 December 2023
Estimated completion	10 December 2023
Sites	1 location across United States

Drugs / interventions tested

Therapeutic Endoscopic Ultrasound

Conditions studied

Therapeutic Endoscopic Ultrasound — all drugs for Therapeutic Endoscopic Ultrasound →
Advanced Endoscopy — all drugs for Advanced Endoscopy →
Therapeutic Endoscopy — all drugs for Therapeutic Endoscopy →
Interventional Endoscopy — all drugs for Interventional Endoscopy →

Sponsor

Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University

Who can join

Eligibility, any sex, with Therapeutic Endoscopic Ultrasound or Advanced Endoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this retrospective chart-review registry study is to evaluate the safety profile, efficacy profile and cost-effectiveness of the various therapeutic endoscopic ultrasound (EUS) procedures (for benign and malignant gastrointestinal disorders). 1. To assess the clinical and technical success rates of EUS-Guided interventions 2. To document the impact of therapeutic EUS procedures on the management of gastrointestinal disorders including malignancies through cost effective analyses. 3. Compare endoscopic interventions to non-endoscopic interventions for the same clinical indications and evaluate safety and efficacy.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Endoscopic Ultrasound-Guided Gallbladder Drainage Versus Percutaneous Drainage in Patients With Acute Cholecystitis Undergoing Elective Cholecystectomy.
Tyberg A, Duarte-Chavez R, Shahid HM, Sarkar A, et al · · 2023 · cited 22× · PMID 37141073 · DOI 10.14309/ctg.0000000000000593
Invasive CO <sub>2</sub> monitoring with arterial line compared to end tidal CO <sub>2</sub> during peroral endoscopic myotomy.
Duarte-Chavez R, Tyberg A, Sarkar A, Shahid HM, et al · · 2023 · cited 2× · PMID 37180312 · DOI 10.1055/a-2048-1312
Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography.
Karanfilian B, Tyberg A, Sarkar A, Shahid HM, et al · · 2024 · PMID 38713274 · DOI 10.1007/s10620-024-08454-1

Verify or expand the search:

Other Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University trials

Trials by the same sponsor.

NCT05041608 — Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05051358 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Last refreshed: 26 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing